Phase I trial of imatinib mesylate, hydroxyurea and vatalanib for patients with recurrent glioblastoma multiforme (GBM)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sathornsumetee, S; Rich, JN; Vredenburgh, JJ; Desjardins, A; Quinn, JA; Gururangan, S; Egorin, MJ; Salvado, AJ; Friedman, HS; Reardon, DA

Published Date

  • June 20, 2007

Published In

Volume / Issue

  • 25 / 18

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X